COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?

Stella Papachristou1, Theano Penlioglou1, Anca Pantea Stoian2

  • 1Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.

Insights

The COVID-19 pandemic disproportionately affects older adults and individuals with diabetes mellitus (DM). Many COVID-19 fatalities, particularly in Italy, were linked to pre-existing DM.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic, declared by the WHO, presents a significant global health challenge.
  • Increased mortality and morbidity rates are observed in elderly populations and individuals with comorbidities.
  • Diabetes mellitus (DM) is a prevalent comorbidity associated with severe COVID-19 outcomes.

Purpose of the Study:

  • To highlight the heightened risk of severe outcomes and mortality in elderly individuals with COVID-19.
  • To emphasize the significant role of diabetes mellitus (DM) as a comorbidity in COVID-19.
  • To present data on the prevalence of DM among COVID-19 fatalities.

Main Methods:

  • Literature review and data synthesis on COVID-19 impact.
  • Analysis of mortality data stratified by age and comorbidities.
  • Epidemiological surveillance data interpretation.

Main Results:

  • COVID-19 mortality and morbidity are significantly higher in the elderly.
  • Individuals with comorbidities like DM face elevated risks.
  • In Italy, two-thirds of COVID-19 deaths were among individuals with DM.

Conclusions:

  • Elderly individuals and those with DM are a vulnerable population during the COVID-19 pandemic.
  • Diabetes mellitus is a critical factor contributing to COVID-19 severity and mortality.
  • Public health strategies must prioritize these high-risk groups.

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
112
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
135.7K
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
9.0K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
503
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.8K